PPH Legal Blog

Over a dozen new Avandia lawsuits were filed in late August, after many more people have suffered the dangerous effects of Avandia, a drug meant to treat diabetes. The new lawsuits have one common claim - patients were never warned about the dangerous effects of the drug.
Many people have developed a heart condition known as […]

[Read more →]

Lany Standford, a type 2 diabetic, died after suffering a heart attack in May, 2007. He had been prescribed Avandia to regulate his insulin levels; however, the drug turned out to be more dangerous than the condition it was meant to treat.
Stanford’s family has filed a wrongful death lawsuit against the manufacturer, GlaxoSmithKline. According to […]

[Read more →]

In early July, GeneraMedix was approved by the FDA for its Epoprostenol for injection 1.5mg drug. GeneraMedix’s Epoprostenol for injection 1.5mg is meant to be a long-term intravenous treatment for primary pulmonary hypertension (PPH).
PHH is caused by the thinning or narrowing of the blood vessels that supply the lungs. If left untreated, an individual’s blood […]

[Read more →]

A Massachusetts teenager, Cassie Tessier, is awaiting a double lung transplant that will save her life.  Tessier currently has a pill regiment four times a day, frequent blood transfusions, oxygen supplementation, and has a pump that helps move the medication more efficiently into her heart.
Tessier was diagnosed in 2000 with pulmonary hypertension, a rare and debilitating blood […]

[Read more →]

An Ohio woman, Carol Dickson, had struggled for years to catch her breath while moving about town.  Finally, after a hospitalization and near death experience, she was diagnosed with Pulmonary Hypertension.  Diseases like Pulmonary Hypertension adversely limits the body’s ability to distribute oxygen, making patients feel short of breath and dizzy, unwilling and unable to […]

[Read more →]